SCHEMBL1303650

SCHEMBL1303650

Cn1c(-c2ccn(C3CC3)n2)nc(-c2ccc(-c3ncon3)cc2)c1Sc1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 7/20 0.43
KCNH2 Q12809 1/20 0.43
SLC2A1 P11166 2/20 0.34
MAPT P10636 2/20 0.32
SLC2A2 P11168 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
S1PR2 O95136 1/20 0.31
TDP2 O95551 1/20 0.31
S1PR4 O95977 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
RAF1 P04049 1/20 0.31
POLB P06746 1/20 0.31
THRB P10828 1/20 0.31
HPGD P15428 1/20 0.31
S1PR1 P21453 1/20 0.31
MAPK1 P28482 1/20 0.31
CTNNB1 P35222 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1303886 0.88 FAAH (0.48) FAAHKCNH2SLC2A1MAPTSLC2A2
SCHEMBL8007745 0.88 FAAH (0.35) FAAHKCNH2
SCHEMBL1304105 0.84 FAAH (0.45) FAAHKCNH2SLC2A1MAPTSLC2A2
SCHEMBL1324521 0.84 FAAH (0.45) FAAHKCNH2SLC2A1MAPTSLC2A2
SCHEMBL1302358 0.82 FAAH (0.43) FAAHMEN1ALDH1A1LMNAKMT2A
SCHEMBL8011218 0.81 FAAH (0.40) FAAHLMNAMAPK1HTTSMN1; SMN2
SCHEMBL7993038 0.80 FAAH (0.62) FAAHKCNH2SLC2A1MAPTSLC2A2
SCHEMBL7993050 0.80 FAAH (0.44) FAAHKCNH2SLC2A1MAPTSLC2A2
SCHEMBL1303011 0.80 FAAH (0.50) FAAHKCNH2SLC2A1MAPTKDM4E
SCHEMBL8002873 0.79 FAAH (0.51) FAAHKCNH2SLC2A1SLC2A2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US claimed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US claimed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885KCNH2 1076/4885SLC2A1 1327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.